{
    "clinical_study": {
        "@rank": "92479", 
        "arm_group": [
            {
                "arm_group_label": "Smartpatch Group 1", 
                "arm_group_type": "Experimental", 
                "description": "Subjects in Group 1 will have a Smartpatch Lead placed in the residual limb in location 1 in the upper leg. These subjects will then use the Smartpatch Peripheral Nerve Stimulation (PNS) System and will receive electrical stimulation."
            }, 
            {
                "arm_group_label": "Smartpatch Group 2", 
                "arm_group_type": "Experimental", 
                "description": "Subjects in Group 2 will have Smartpatch Lead(s) placed in the residual limb in location 2 in the upper leg. These subjects will use the Smartpatch Peripheral Nerve Stimulation (PNS) System and will receive electrical stimulation."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine if electrical stimulation (small levels of\n      electricity) can safely and effectively reduce post-amputation pain. This study involves a\n      device called the Smartpatch System. The Smartpatch System delivers mild electrical\n      stimulation to nerves in the residual limb. The Smartpatch System includes a small wire\n      (called a \"lead\") that is placed through the skin in the upper leg. It also includes a\n      device worn on the body that delivers stimulation (called the Smartpatch Stimulator)."
        }, 
        "brief_title": "Electrical Stimulation for the Treatment of Post-Amputation Pain Using the Smartpatch System", 
        "condition": [
            "Post-Amputation Pain", 
            "Phantom Limb Pain", 
            "Residual Limb Pain"
        ], 
        "condition_browse": {
            "mesh_term": "Phantom Limb"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Key Inclusion Criteria:\n\n          -  At least 18 years old\n\n          -  Traumatic lower extremity amputation(s)\n\n          -  Healed amputation and healthy residual limb based upon the investigator's evaluation\n\n        Key Exclusion Criteria:\n\n          -  Change of prescribed medications affecting pain within the past 4 weeks\n\n          -  Compromised immune system based on medical history\n\n          -  Implanted electronic device\n\n          -  Bleeding disorder\n\n          -  History of valvular heart disease\n\n          -  Confounding central nervous system injuries and disorders\n\n          -  History of recurrent skin infections"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "54", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01996254", 
            "org_study_id": "0123-CSP-000"
        }, 
        "intervention": {
            "arm_group_label": [
                "Smartpatch Group 1", 
                "Smartpatch Group 2"
            ], 
            "description": "The Smartpatch System is an Investigational Device which delivers mild electrical stimulation to nerves in the residual limb. The Smartpatch System includes a small wire (called a \"Lead\") that is placed through the skin in the upper leg. It also includes a device worn on the body that delivers stimulation (called the Smartpatch Stimulator).", 
            "intervention_name": "Smartpatch Peripheral Nerve Stimulation (PNS) System", 
            "intervention_type": "Device", 
            "other_name": "Smartpatch System, Smartpatch"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "electrical stimulation", 
            "neurostimulation", 
            "neuromodulation", 
            "post-amputation pain", 
            "phantom limb pain", 
            "residual limb pain", 
            "neuropathic pain"
        ], 
        "lastchanged_date": "November 21, 2013", 
        "link": [
            {
                "description": "Collaborator's Website", 
                "url": "http://www.sprtherapeutics.com"
            }, 
            {
                "description": "Sponsor's Website", 
                "url": "http://www.ndimedical.com"
            }, 
            {
                "description": "Study Recruitment Website", 
                "url": "http://www.amputeepainstudy.com"
            }
        ], 
        "location": {
            "contact": {
                "last_name": "Jamie Southern", 
                "phone": "336-765-6181"
            }, 
            "facility": {
                "address": {
                    "city": "Winston Salem", 
                    "country": "United States", 
                    "state": "North Carolina", 
                    "zip": "27103"
                }, 
                "name": "Center for Clinical Research"
            }, 
            "investigator": {
                "last_name": "Richard Rauck, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized, Double-Blinded, Controlled, Parallel Group, Multicenter Pilot Study of the Smartpatch Peripheral Nerve Stimulation (PNS) System for the Treatment of Post-Amputation Pain", 
        "overall_official": {
            "affiliation": "NDI Medical", 
            "last_name": "Josh Boggs, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "United States: Institutional Review Board"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Change from Baseline Pain Intensity at End of Treatment (EOT)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, End of Treatment (4-weeks of Stimulation)"
            }, 
            {
                "measure": "Device related adverse event rates", 
                "safety_issue": "Yes", 
                "time_frame": "24-48 hours of stimulation"
            }, 
            {
                "measure": "Device related adverse event rates", 
                "safety_issue": "Yes", 
                "time_frame": "1-week of stimulation"
            }, 
            {
                "measure": "Device related adverse event rates", 
                "safety_issue": "Yes", 
                "time_frame": "2-weeks of stimulation"
            }, 
            {
                "measure": "Device related adverse event rates", 
                "safety_issue": "Yes", 
                "time_frame": "3-weeks of stimulation"
            }, 
            {
                "measure": "Device related adverse event rates", 
                "safety_issue": "Yes", 
                "time_frame": "End of treatment (4-weeks of Stimulation)"
            }, 
            {
                "measure": "Device related adverse event rates", 
                "safety_issue": "Yes", 
                "time_frame": "1-week post-treatment"
            }, 
            {
                "measure": "Device related adverse event rates", 
                "safety_issue": "Yes", 
                "time_frame": "4-weeks post-treatment"
            }, 
            {
                "measure": "Device related adverse event rates", 
                "safety_issue": "Yes", 
                "time_frame": "12-weeks post-treatment"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01996254"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change from Baseline Pain Interference at End of Treatment", 
                "safety_issue": "No", 
                "time_frame": "Baseline, End of Treatment (4-weeks of Stimulation)"
            }, 
            {
                "measure": "Durability of change from baseline Pain Intensity at 12-weeks beyond Treatment", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 12-weeks post-treatment"
            }, 
            {
                "measure": "Durability of change from baseline Pain Interference at 12-weeks beyond Treatment", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 12-weeks post-treatment"
            }, 
            {
                "measure": "Patient Global Impression of Change at End of Treatment", 
                "safety_issue": "No", 
                "time_frame": "End of Treatment (4-weeks of Stimulation)"
            }, 
            {
                "measure": "Change from Baseline Average Residual Limb Pain Intensity at End of Treatment", 
                "safety_issue": "No", 
                "time_frame": "Baseline, End of Treatment (4-weeks of Stimulation)"
            }, 
            {
                "measure": "Change from Baseline Average Phantom Limb Pain Intensity at End of Treatment", 
                "safety_issue": "No", 
                "time_frame": "Baseline, End of Treatment (4-weeks of Stimulation)"
            }, 
            {
                "measure": "Change from Baseline Worst Residual Limb Pain Intensity at End of Treatment", 
                "safety_issue": "No", 
                "time_frame": "Baseline, End of Treatment (4-weeks of Stimulation)"
            }, 
            {
                "measure": "Change from Baseline Worst Phantom Limb Pain Intensity at End of Treatment", 
                "safety_issue": "No", 
                "time_frame": "Baseline, End of Treatment (4-weeks of Stimulation)"
            }, 
            {
                "measure": "Change in Pain Analgesic Usage at End of Treatment", 
                "safety_issue": "No", 
                "time_frame": "End of Treatment (4-weeks of Stimulation)"
            }, 
            {
                "measure": "Change from Baseline Depression (BDI-II) at End of Treatment", 
                "safety_issue": "No", 
                "time_frame": "Baseline, End of Treatment (4-weeks of Stimulation)"
            }, 
            {
                "measure": "Change from Baseline Pain Disability at End of Treatment", 
                "safety_issue": "No", 
                "time_frame": "Baseline, End of Treatment (4-weeks of Stimulation)"
            }, 
            {
                "measure": "Change from Baseline Prosthetic usage at End of Treatment", 
                "safety_issue": "No", 
                "time_frame": "Baseline, End of Treatment (4-weeks of Stimulation)"
            }
        ], 
        "source": "NDI Medical, LLC", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "SPR Therapeutics, LLC", 
                    "agency_class": "Industry"
                }, 
                {
                    "agency": "Department of Defense", 
                    "agency_class": "U.S. Fed"
                }
            ], 
            "lead_sponsor": {
                "agency": "NDI Medical, LLC", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}